Vestas Wind Systems Shares Slip as Margins Expected at Low End of Guidance US Stock Futures and Bond Yields Fall on Reports Putin Updated Nuclear Doctrine RBIs Record 287 Lakh Crore Dividend Transfer Bolsters Fiscal Flexibility Amid Global Headwinds Housing and Climate Resilience Top Latin American Agenda at World Urban Forum 13 Global Markets Track Wall Street Records as Oil Prices Retreat 2 Monster Stocks to Hold for the Next 10 Years LongTerm Growth Perspectives ERII Q1 2026 Earnings EPS Miss Highlights Ongoing Cost Pressures Despite Stock Gain Nuburu Inc BURU Q3 2023 Earnings Net Loss Reported as Company Advances Industrial Laser Commercialization Pathward Financial Inc CASH Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Underlying Strength MSM Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Environment MCB Q1 2026 Earnings Strong EPS Beat Amid Solid Core Performance Nextpower Inc NXT Edges Lower as Stock Consolidates Near Key Support Levels Perimeter Acquisition Corp I Unit PMTRU Posts Moderate Gain Testing Resistance ITT Inc ITT Slips 248 After Recent Rally Testing Key Support Levels Science Applications International Corporation SAIC Rebounds Near Key 100 Level Vine Hill Capital Investment Corp VCIC Drops 654 as Bearish Momentum Builds Trump Mobile Investigates Potential Data Exposure Affecting 27000 WouldBe Customers NRX Pharmaceuticals Inc Q1 2026 Earnings EPS Misses Estimates Stock Declines Modiv Industrial MDV Edges Higher Key Levels in Focus After 14 Gain XFOR Q1 2026 Earnings EPS Beats Estimates Despite Continued PreRevenue Status Stock Declines SION Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline MDB Q1 2026 Earnings EPS Beats Estimates by 127 Stock Slips 35 Origin Bancorp Inc OBK Q1 2026 Earnings EPS Misses Estimates Amid Interest Rate Headwinds CNTN Q4 2023 Earnings NarrowerThanExpected Loss Drives Share Uptick RM Q1 2026 Earnings EPS Surges Past Estimates as Regional Management Posts Strong Profit Beat PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response